Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression  by Raetzman, L.T et al.
www.elsevier.com/locate/ydbio
Developmental Biology 265 (2004) 329–340Developmental regulation of Notch signaling genes in the embryonic
pituitary: Prop1 deficiency affects Notch2 expression
L.T. Raetzman,a,1 S.A. Ross,b,1 S. Cook,b S.L. Dunwoodie,c,d
S.A. Camper,a and P.Q. Thomasb,e,*
aHuman Genetics, University of Michigan Medical School, Ann Arbor, MI 48109-0638, USA
bMurdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, VIC 3052, Australia
cVictor Chang Cardiac Research Institute, St. Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
dDepartment of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, NSW 2033, Australia
eDepartment of Paediatrics, University of Melbourne, Victoria 3010, AustraliaReceived for publication 1 May 2003, revised 19 September 2003, accepted 19 September 2003Abstract
Normal development of the pituitary gland requires coordination between the maintenance of a progenitor cell pool and the selection of
progenitor cells for differentiation. As Notch signaling controls progenitor cell differentiation in many embryonic tissues, we investigated the
involvement of this important developmental pathway in the embryonic pituitary. We report that expression of Notch signaling genes is
spatially and temporally regulated in pituitary embryogenesis and implicate Notch2 in the differentiation of several cell lineages. Notch2,
Notch3, and Dll1 are initially expressed by most cells within the pituitary primordium and become restricted to a subset of the progenitor cell
pool as differentiated pituitary cells begin to appear. Mutations in the transcription factor Prop1 interfere with pituitary growth and cell
specification, although the mechanism is unknown. Notch2 expression is nearly absent in the developing pituitaries of Prop1 mutant mice,
but unaltered in some other panhypopituitary mutants, revealing that Prop1 is directly or indirectly required for normal Notch2 expression.
Transgenic overexpression of Prop1 is not sufficient for enhancement of endogenous Notch2 expression, indicating that there are multiple
inputs into this pathway. Dll3 is expressed only in the presumptive corticotrope and melanotrope cells. Analysis of Dll3 null mutants
indicates that Dll3 is not required for specification of these two cell types, although there may be functional overlap with Dll1. The spatial
and temporal expression patterns of Notch signaling genes in the pituitary suggest overlapping roles in pituitary growth and cell specification.
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Introduction et al., 2002; Scully and Rosenfeld, 2002). This information,The function of the pituitary gland is largely conserved
across vertebrate evolution, and the hormone-secreting cells
appear in a spatially and temporally regulated pattern (Japon
et al., 1994; Kawamura et al., 2002; Simmons et al., 1990;
Sloop et al., 2000). In recent years, many of the key
signaling molecules and transcriptional regulators that con-
trol pituitary organogenesis have been identified (Cushman0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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promoters and well-defined cell phenotypes, makes the
pituitary an excellent system to investigate critical develop-
mental events including progenitor cell commitment and
differentiation.
All hormone-secreting cells of the anterior and interme-
diate lobes are derived from a common primordium,
Rathke’s pouch (RP). The anterior pituitary has five hor-
mone-secreting cell types that are defined by their hormone
products. These terminally differentiated cell types (and
their secreted products) are corticotropes (adrenocorticotro-
phic hormone, ACTH), thyrotropes (thyroid stimulating
hormone, TSH), somatotropes (growth hormone, GH), lac-
totropes (prolactin, PRL), and gonadotropes (follicle-stimu-
lating hormone [FSH] and luteinizing hormone [LH]). An
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which secretes alpha melanocyte-stimulating hormone
(aMSH) and resides within the intermediate lobe. In the
murine embryo, RP forms at approximately 9.5 days post-
coitum (dpc) from an invagination of oral ectoderm at the
anterior ventral midline. During 9.5–12.5 dpc, RP expands
and extends dorsally to contact the infundibular recess, and
then detaches from the oral ectoderm to become a ‘‘flat-
tened’’ ball of cells. Loss-of-function, ectopic expression
and explant culture experiments suggest that signaling
molecules from neighboring tissues, which include BMP4,
FGF8, FGF10, SHH, BMP2, WNT4, WNT5A, and chordin,
specify cell fate within the pituitary primordium during this
initial phase (Ericson et al., 1998; De Moerlooze et al.,
2000; Ohuchi et al., 2000; Treier et al., 1998, 2001). The
overall effect of these signaling molecules is to induce
regionally restricted expression of transcription factors that
specify cell fate through activation of specific target genes.
The best characterized example of this inductive interaction
is the localized expression of the LIM domain transcription
factors Lhx3 and Isl1 in response to FGF8 signaling from
the infundibulum and opposing BMP signaling from the
ventral mesenchyme (Ericson et al., 1998). This process is
critical for the determination of corticotropes and the rostral
tip thyrotropes (a minor thyrotrope population that expresses
aGSU and TSHh, but differs from most thyrotropes by
lacking the transcription factor PIT1). The remaining cell
types emerge over the next few days, in response to
activation of additional transcription factors that are sensi-
tive to positional information, such as GATA2 (Dasen et al.,
1999). The mechanism for establishing the border between
the differentiation of the anterior lobe and the intermediate
lobe is unknown.
One of the key components of the genetic program that
controls progenitor cell differentiation in the developing
pituitary is Prop1. A hypomorphic mutation of Prop1,
which was originally identified in the Ames dwarf mutant
(Prop1df/df), causes severe pituitary hypoplasia and a mas-
sive reduction in somatotropes, lactotropes, and thyrotropes,
and reduced gonadotrope function (Gage et al., 1996;
Sornson et al., 1996; Tang et al., 1993). Interestingly,
several PROP1 mutations have been identified in humans
with multiple pituitary hormone deficiency (Agarwal et al.,
2000; Wu et al., 1998), underlining the conserved role of
this homeoprotein in the pituitary. Prop1 expression is
pituitary-specific and is initially enriched in the rapidly
proliferating progenitor cells that line the lumen of RP
(Ikeda and Yoshimoto, 1991; Sornson et al., 1996). At
14.5 dpc, mutant pituitaries are dysmorphic and contain
an excess of peri-luminal progenitor cells (Raetzman et al.,
2002). The presumptive anterior lobe, which lies immedi-
ately ventral to the peri-luminal cells, is severely hypocel-
lular in Prop1 mutant pituitaries. These data indicate that
Prop1 is essential for the exit of peri-luminal progenitor
cells from the high-proliferation zone and their subsequent
differentiation. However, the precise mechanism by whichProp1 controls progenitor cell commitment and differentia-
tion remains to be determined. Mutant pituitaries also
contain cells that are not clearly fated to become anterior
or intermediate lobe cells, suggesting a problem with
establishing borders of expression.
Insight into the genetic basis of the Prop1df/df mutant
phenotype has come from the identification of target
genes for this transcription factor. Prop1df/df mice do not
activate Pit1 gene expression, and subsequently fail to
generate somatotropes, lactotropes, and thyrotropes, re-
vealing that Prop1 is required for activation of Pit1 (Gage
et al., 1996; Sornson et al., 1996). Furthermore, there is a
temporal extension of Hesx1 expression in Prop1df/df
mice, revealing that Prop1 is required for the extinction
of Hesx1. Prop1 is also essential for repressing the
expression of the gonadotrope marker SF1 (Nr5a1) in
the dorsal region of the anterior lobe (Raetzman et al.,
2002). The identification of additional target genes for
Prop1 is essential for a complete understanding of the
complex phenotype that results from Prop1 mutation in
mice and man.
The Notch signaling pathway is an evolutionarily con-
served mechanism that controls cellular differentiation,
proliferation, and death in a broad spectrum of develop-
mental systems (Artavanis-Tsakonas et al., 1999; Beatus and
Lendahl, 1998). The core pathway components were orig-
inally identified in Drosophila and include a transmembrane
receptor (Notch), two transmembrane ligands (Delta and
Serrate), and an activator of transcription (Suppressor of
Hairless, Su(H)). Notch signaling is initiated by interaction
between the extracellular domains of the ligand and recep-
tor. This results in cleavage of the intracellular domain of
the receptor and translocation to the nucleus, where through
interaction with Su(H), target genes are activated. One of the
best characterized developmental events that is controlled
by Notch signaling is the generation of neuroblasts in
Drosophila by a process termed lateral inhibition. In this
system, neuroblasts that emerge from a progenitor cell pool
(equivalence group) express high levels of Delta, which
interacts with Notch receptors on neighboring cells to
prevent them from adopting a neural fate. Many studies
have also shown that Notch signaling plays a major role in
inhibition of progenitor cell differentiation, particularly
within the vertebrate CNS, although it can also promote
differentiation of progenitors to glial cell fates (reviewed by
Gaiano and Fishell, 2002; Lewis, 1998). In addition, Notch
signaling is required to direct cell fate during differentiation
in a wide range of developmental contexts such as glomer-
ular differentiation and patterning in mammals (McCright et
al., 2001).
Mammals have multiple homologs for the Notch receptor
(Notch 1, 2, 3, 4) and ligands (Delta-like 1, 3, 4, Jagged1
and Jagged2). Expression of these genes is spatially and
temporally restricted during embryogenesis, indicating that
Notch signaling is used to control cellular differentiation in
many tissues. The developmental role of these genes has
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and the identification of mutations in patients with congen-
ital abnormalities. However, their role in the developing
pituitary has not been explored. To investigate this, we
examined the expression of Notch signaling genes during
the commitment and differentiation of pituitary cell line-
ages. Notch2, Notch3, and Delta-like1 (Dll1) are expressed
in the peri-luminal progenitor cells of RP. In contrast, Delta-
like 3 (Dll3) expression is restricted to the melanotropes and
early corticotropes, and may be functionally redundant with
Dll1 during differentiation of these lineages. We examined
Notch family gene expression in Prop1df/df mutant mice to
determine whether the cell specification failure correlates
with alterations in pattern or level of Notch gene expression.
Notch2 mRNA and protein is dramatically reduced at 12.5
dpc and absent at 14.5 dpc in these mutants, indicating that
Notch2 may be involved in the emergence of terminally
differentiated cell types during pituitary development. These
data suggest that the Notch signaling pathway may play a
role in the commitment and lineage-specific differentiation
of progenitor cells in the embryonic pituitary, in particular,
Prop1-dependent cell lineages.Materials and methods
In situ hybridization
Mouse embryos were fixed for 18 h at 4jC in parafor-
maldehyde (4% w/v in PBS) and then placed in sucrose
(20% w/v in PBS) until they sunk. After embedding in OCT
(TissueTek), 16-Am cryostat frozen sections were prepared
and mounted onto Superfrost-Plus slides. Gene expression
was detected by hybridizing digoxigenin-labeled antisense
riboprobes as described previously (Dunwoodie et al., 1997).
The Pomc1 riboprobe spans nucleotides 1–533 bp (Accn.
No. NM_008895), the aGSU (Cga) probe spans nucleotides
42–636 (Accn. No. NM_009889), and the Prop1 probe used
in Fig. 1 corresponds to nucleotides 585–985 (Accn. No.
NM_008936). Prop1 expression in Fig. 4 was detected using
an antisense probe as previously described (Cushman et al.,
2001). Dll1, Dll3, Serrate1, Hes1, Hes5, Hes6, Notch1,
Notch2, and Notch3 probes were prepared as described
previously (Akazawa et al., 1992; Dunwoodie et al., 1997;
Kusumi et al., 2001; Tomita et al., 1996; Vasiliauskas and
Stern, 2000). At least four embryos were examined for each
time point and genotype.
Northern blot analysis
Total RNA was prepared from AtT-20 cells and homog-
enized 10.5 dpc embryos using TRIzol. Poly(A) RNA
extraction and Northern blot analysis was performed as
described previously (Dunwoodie et al., 1997), and the
filter exposed to X-ray film for 16 h (X-OMAT, Kodak,
Australia).Mice
Ames dwarf mice (DF/B-Prop1df/df) were obtained from
Dr. A. Bartke (Southern Illinios University, Carbondale,
IL) and have been maintained at the University of Mich-
igan. Transgenic mice with constitutive Prop1 expression
were created with the aGSU promoter and Prop1 genomic
sequences as previously described, TgN(Cga-Prop1)D6
(Cushman et al., 2001). Mice carrying a null allele for
Dll3 were maintained at the Victor Chang Cardiac Re-
search Institute (Sydney) on a C57BL/6 genetic back-
ground. Embryos were collected from timed pregnant
Ames dwarf and TgN(Cga-Prop1)D6 transgenic founder
mice, with the day the vaginal plug was detected desig-
nated as 0.5 dpc. TgN(Cga-Prop1)D6, Prop1df/df, and Dll3
embryos were genotyped from genomic DNA as described
previously (Cushman et al., 2001; Dunwoodie et al.,
1997). Embryos used in Figs. 1 and 5 were HSDola-Swiss
strain from the breeding colony at Melbourne University,
Australia.
Immunohistochemistry
Embryos were fixed for 2–24 h in paraformaldehyde (4%
w/v in PBS), dehydrated, and embedded in paraffin. Six-
micrometer sagittal and coronal sections of these embryos
were prepared and immunostained for NOTCH2. For this
purpose, slides were boiled in (10 mM) citric acid, pH 6, for
10 min for epitope retrieval and incubated with the mouse
monoclonal NOTCH2 antibody (1:1500, C651.6DbHN De-
velopmental Studies Hybridoma Bank [DSHB], University
of Iowa, Iowa City, IA), which was diluted in PBS contain-
ing BSA (3%), Tween-20 (0.5%), and normal goat serum
(5% w/v) overnight at 4jC. Antibody detection was carried
out with the TSA kit (Perkin-Elmer) according to the
manufacturer’s protocol. Five wild-type and mutant embryo
pairs were analyzed at each time point.Results
Notch2, Notch3, and Dll1 are expressed in progenitor cells
of the anterior pituitary
To determine whether Notch signaling genes are active
during the commitment and differentiation of anterior pitu-
itary lineages, we examined the expression of Notch recep-
tor and ligands at 12.5 and 14.5 dpc using in situ
hybridization. During this period of development, differen-
tiated cell types appear in the ventro-anterior quadrant of the
anterior pituitary primordium. The majority of these cells
express aGSU, officially named Cga, a marker for thyro-
tropes and gonadotropes (Figs. 1C, D). Proliferating cells
are detected almost exclusively in the peri-luminal region of
RP (Ikeda and Yoshimoto, 1991; Raetzman et al., 2002).
These cells are likely progenitors for somatotropes, lacto-
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F). At 12.5 dpc, Notch2 is expressed in the progenitor cell
population and is at highest levels in the peri-luminal cells
of RP (Fig. 1G). Notch2 expression is maintained at high
levels in the region containing Prop1-positive peri-luminal
cells at 14.5 dpc (Fig. 1H and data not shown), but it is not
detected in the region that contains differentiated, aGSU-
positive cells. At 14.5 dpc, clusters of Notch2-positive cells
are also evident in the anterior pituitary in regions that
express Prop1. Notch2 is co-expressed with Prop1 and
appears to be restricted to a portion of the progenitor cell
pool, forming a border between the proliferating precursor
cells and the differentiated hormone-producing cells. Notch3
(Fig. 1I) and the ligand Dll1 (Fig. 1K) are also expressed by
most progenitor cells at 12.5 dpc, and like Notch2, become
restricted to a subset of these cells by 14.5 dpc (Figs. 1J, L),
with highest expression in the peri-luminal progenitor cells.
Notch1 and Serrate1 expression was not detected in the
developing anterior pituitary at 12.5 and 14.5 dpc. Tran-
scription of Notch receptors and ligands in the progenitor
cell pool support a role for Notch signaling in the develop-
ment of the anterior pituitary.
Notch2 expression is dramatically reduced in Prop1
mutants
Prop1 acts as a transcriptional activator and repressor.
It is expressed within the progenitor cells of the embry-
onic pituitary, and it is essential for differentiation of the
PIT1 lineages (thyrotropes, somatotropes, and lactotropes).
PROP1 may influence all of the cell types of the anterior
lobe, as humans with PROP1 mutations consistently exhibit
gonadotropin deficiency and occasionally exhibit acquired
ACTH deficiency (Agarwal et al., 2000; Parks and Brown,
1999; Pernasetti et al., 2000; Wu et al., 1998). At 14.5 dpc,
mutant pituitaries appear to have an overabundance of peri-
luminal progenitor cells and hypoplastic anterior lobes,
indicating an inability of Prop1 deficient progenitors to
differentiate. The only known target genes of PROP1,
namely Hesx1, Pit1, and Nr5a1, do not explain the dysmor-
phic, hypoplastic phenotype of Prop1df/df mutants.Fig. 1. Temporal and spatial expression patterns of Notch signaling genes
correspond with undifferentiated cells of the pituitary gland. Panels A (12.5
dpc) and B (14.5 dpc) present schematic diagrams of the developing
pituitary in sagittal section. Green represents the infundibulum, light blue
the diencephalon, yellow the intermediate lobe, red the progenitor cells of
the presumptive anterior pituitary, and dark blue the rostral tip thyrotropes.
The remaining panels represent the comparison of aGSU, Prop1, Notch2,
Notch3, and Dll1 expression at 12.5 dpc (C, E, G, I, K) and 14.5 dpc (D, F,
H, J, L) by in situ hybridization. aGSU marks the differentiated cells in the
ventro-anterior domain (C, D). Prop1 is expressed by the progenitor cells
and is excluded from the aGSU-positive differentiated cells in the ventro-
anterior quadrant (E, F). Notch2 expression is restricted to progenitor cells
and overlaps extensively with Prop1 expression (G, H). Panels F and H are
consecutive serial sections. Notch3 (I, J) and Dll1 (K, L) expression is
enriched in progenitor cells. Dll1 is also expressed throughout the entire
prospective IL.
Fig. 2. Prop1 is required for pituitary expression of Notch2. Immunohistochemical detection of NOTCH2 in sagittal sections of wild-type (A, C, E) and Prop1
mutant pituitaries (B, D, F) at 12.5 dpc (A, B), 14.5 dpc (C, D) and 16.5 dpc (E, F). NOTCH2 is present in the ventral aspect of RP and isolated cells in the
anterior lobe at 12.5 and 14.5 dpc in wild-type mice, but little or no NOTCH2 was detected in Prop1df/df pituitaries at these ages. By 16.5 dpc, NOTCH2 is
restricted to cells near the lumen in wild-type mice and is still not detectable in Prop1df/df pituitaries. Five embryos of each genotype at each age were examined.
L.T. Raetzman et al. / Developmental Biology 265 (2004) 329–340 333The coincident pattern of Prop1 and Notch family gene
expression suggested that one or more of the Notch genes
might be downstream of Prop1. To assess this possibility,
we analyzed expression of the Notch genes in Prop1df/df
mutant mice. At 12.5 dpc, Notch2 expression decreased
dramatically in the developing pituitary of the Prop1df/df
mutants relative to their normal littermates, but expression
remained unchanged in the surrounding mesenchyme (Figs.
2A, B). By 14.5 dpc, Notch2 protein is completely absent
from the Prop1 mutant pituitary (Fig. 2D). The loss of
Notch2 expression is specific to Prop1 deficiency, as Notch2
transcripts were detectable in hypoplastic pituitaries that
result from lesions in Hesx1 or Lhx4 (data not shown).
These data suggest that Notch2 is dependent on Prop1 either
directly or indirectly, and that Notch2 expression affects the
emergence of terminally differentiated cell types during
pituitary development. In contrast, Notch3 expression is
not altered in the Prop1df/df mutants (Figs. 3A, B). This
indicates that the lack of Notch2 expression in mutant
pituitaries is not due to an absence of progenitor cells andthat Notch2 and Notch3, despite their similar expression, are
regulated differently.
A key feature of lateral inhibition is the ability of
progenitor cells to down-regulate expression of Notch
ligand in response to Notch receptor activation by neigh-
boring cells. The absence of Notch2 expression in Prop1df/df
progenitor cells therefore suggests that there may be an
inability of progenitor cells to respond to DLL1 ligand
signaling, resulting in increased expression of the ligand.
To test this possibility, we examined expression of Dll1 in
the Prop1df/df pituitary at 14.5 dpc. The expression of Dll1 is
slightly and consistently elevated in pituitaries of Prop1
mutants (Fig. 3D) relative to wild-type mice (Fig. 3C). This
indicates that decreased Notch2 expression coincides with
elevated Dll1 expression in the pituitary gland and is
consistent with models of lateral inhibition that operate in
other systems (de la Pompa et al., 1997; Heitzler et al., 1996).
The Hes genes are known downstream effectors of the
Notch signaling pathway. We examined the expression of
Hes genes in the pituitary and found that bothHes1 andHes6
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Fig. 4. Overexpression of Prop1 does not alter NOTCH2 protein levels. Prop1 expression is readily detected in two independent lines of transgenic mice (Tg8,
Tg54) at 18.5 dpc by in situ hybridization, but not in wild-type mice at this age. Identical patterns and levels of NOTCH2 expression are detected in transverse
sections of transgenic and wild-type mice at 18.5 dpc by immunohistochemistry.
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Hes1 and Hes6 have distinct patterns of expression. Hes1 is
localized to RP and is excluded from the anterior lobe in both
wild-type (Fig. 3E) and Prop1 mutants (Fig. 3F). Hes6 is
only present in the developing anterior lobe of wild-type
(Fig. 3G) and Prop1 mutant (Fig. 3H) pituitaries. Hes5 was
not detectable in the pituitary at the time points examined
(data not shown). These data indicate that Notch signaling in
the pituitary is activating Hes genes, but that Hes1 and Hes6
are not changed in response to the loss of Prop1.
Mice overexpressing Prop1 under the control of the
aGSU promoter have delayed gonadotrope development
and a propensity for pituitary tumors (Cushman et al.,
2001). To investigate whether overexpression of Prop1 is
sufficient to alter endogenous Notch2 expression, we gen-
erated transgenic embryos that expressed the Prop1 gene
constitutively, under the control of the 4.6-kb aGSU pro-
moter (Fig. 4). This promoter is active in the progenitor cells
of RP from 9.5 to 12.5 dpc and subsequently activated in the
gonadotrope and thyrotrope lineages (Kendall et al., 1994).
In situ hybridization analysis of Prop1 expression at 18.5
dpc was performed in three independent transgenic embry-
os. As expected, no Prop1 expression was detected in
control embryos at this stage, as endogenous gene expres-Fig. 3. Notch3 is expressed in Prop1-deficient pituitaries and Dll1 is elevated. Rep
12.5 dpc hybridized with the Notch3 riboprobe. Similar levels of expression are se
Prop1df/df (D) pituitaries as compared to wild-type (C) at 12.5 dpc. Hes1 is detecta
12.5 dpc, whereas Hes6 is present only in the anterior lobe at 13.5 dpc of wild-ty
examined at 12.5 and 13.5 dpc with each probe.sion begins to wane by 14.5 dpc. Robust transgene expres-
sion was detected in the prospective IL, just outside the peri-
luminal proliferative zone in the dorsal aspect of the gland,
and in patches throughout the anterior lobe. However,
Notch2 expression was normal in spite of the elevated
expression of Prop1. Therefore, although Prop1 mutants
have greatly diminished Notch2 expression, overexpression
of Prop1 is not sufficient to alter endogenous Notch2
expression at 18.5 dpc. This suggests that Notch2 expres-
sion is regulated by both Prop1-dependent and Prop1-
independent pathways.
Lineage restricted expression of Dll3 in melanotropes and
presumptive corticotropes
Dll3 transcripts were first detected in the presumptive
intermediate lobe (IL) at 13.5 dpc and by 14.5 dpc, and were
present in all cells in this region (Figs. 5A1, B1). At this
stage of pituitary development, the IL contains a single
hormone-secreting cell type, the melanotropes, which
appears at 14.5 dpc and is identified by Pomc1 expression
(Japon et al., 1994). Comparison of Dll3 and Pomc1
expression in 15.5–18.5 dpc embryonic, neonatal, and adult
pituitary tissue indicated that Dll3 is maintained in theresentative sagittal sections of wild-type (A) and Prop1df/df (B) pituitaries at
en in pituitaries of each genotype. In contrast, Dll1 expression is elevated in
ble in the dorsal aspect of both wild-type (E) and Prop1df/df (F) pituitaries at
pe (G) and Prop1df/df (H) pituitaries. Five embryos of each genotype were
Fig. 5. Dll3 marks the prospective intermediate lobe and anterior lobe corticotropes. Dll3 expression is detected in the prospective intermediate lobe
melanotropes by in situ hybridization of sagittal sections of 14.5 dpc embryo (A1). Transverse sections of P1 neonates showing corresponding expression of
Dll3 (A2) and Pomc1 in the intermediate lobe (A3) detected by in situ hybridization. Dll3 is expressed in most of the melanotrope cells that line the residual
lumen of RP. (A2) and (A3) are consecutive serial sections. Dll3 (B1) and Pomc1 (B2) expression domains coincide in 13.5 dpc consecutive serial sagittal
pituitary sections. Low level Dll3 expression is evident in the ventro-anterior domain that contains Pomc1-positive corticotropes. Northern blot analysis of Dll3
expression using 5 Ag of poly(A) selected mRNA from AtT-20 corticotrope cell line and 10.5 dpc embryo (B3). AtT-20 cells express Dll3 at high levels, as
indicated by the 2.2 kb transcript and less abundant 0.8 kb transcript (Dunwoodie et al., 1997). a, anterior lobe; i, intermediate lobe; p, posterior lobe. Arrows
and arrowheads indicate corticotropes and melanotropes, respectively.
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tal stages (Figs. 5A2, A3 and data not shown). However, in
contrast to the embryonic stages, only a subset of the
melanotrope population expresses Dll3 after birth (Figs.
5A2, A3), which may correspond to a residual progenitor
cell population. Proliferating cells that express hormones are
readily detectable after birth, but not prenatally (Taniguchi
et al., 2000, 2001).
Within the developing anterior lobe, low level Dll3
expression was detected at 13.5 dpc in a few scattered cells
in the ventro-anterior domain (Fig. 5B1). These cells also
appear to express Pomc1 indicating that they are cortico-
tropes (Fig. 5B2). Dll3 expression in early stage cortico-
tropes is supported by the high level of Dll3 expression in
the corticotrope cell line AtT-20 (Fig. 5B3). In contrast to
melanotropes, Dll3 expression is not maintained in the
corticotrope lineage (Fig. 5A3).
Functional redundancy of Dll3 and Dll1 during melanotrope
differentiation
The restricted expression of Dll3 to the melanotrope
lineage in the IL suggested that this gene might play a role
in the differentiation and/or maintenance of this cell type. To
explore this possibility, we investigated melanotrope differ-
entiation in Dll3 null mutant embryos (Dunwoodie et al.,
2002) using the Pomc1 marker. Homozygous Dll3 embryoswere compared to either wild-type or heterozygous litter-
mates. Analysis of 13.5–17.5 dpc Dll3 null embryos
revealed no differences in timing or extent of melanotrope
differentiation (Figs. 6A, B). Corticotrope differentiation
also appeared to be unaffected in Dll3 homozygous embryos
(Figs. 6A, B). Analysis of anterior pituitary lineages using
aGSU (thyrotrope and gonadotrope) and Pit-1 (thyrotrope,
somatotrope, and lactotrope) probes revealed normal com-
mitment of these lineages in the Dll3 mutant embryos (data
not shown). Thus, Dll3 is not necessary for specification of
any of the hormone-producing pituitary cell types. Investi-
gation of a role of Dll3 in maintenance or function of
melanotropes or other pituitary cell types is complicated
by the poor viability of the Dll3 mutants (Dunwoodie et al.,
2002; Kusumi et al., 1998).
Normal differentiation of the melanotropes in the absence
of Dll3 indicates that another member of the Notch receptor
family may compensate for the loss of Dll3. At 12.5 dpc,
Dll1 is expressed in most cells within the presumptive
anterior lobe and therefore precedes Dll3 expression in this
region by at least 1 day (Fig. 1K). At 14.5 dpc, Dll1 is
expressed throughout the presumptive IL in a domain that
encompasses the Dll3-positive cells and extends to the
margins of the IL (compare Figs. 1L and 5A1). These data
confirm that Dll3 and Dll1 are co-expressed in the presump-
tive IL and may therefore be functionally redundant during
melanotrope differentiation. In situ hybridization analysis
Fig. 6. Dll3 is not required for Pomc1 expression. In situ hybridization with a Pomc1 probe reveals similar pattern and level of expression in sagittal sections of
16.5 dpc Dll3 +/ (A) and  / (B) embryos. a, anterior lobe; i, intermediate lobe; p, posterior lobe. Arrows and arrowheads indicate corticotropes and
melanotropes, respectively.
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Dll3 mutant embryos (data not shown).Discussion
Notch signaling is an evolutionarily conserved mecha-
nism that controls a broad range of developmental processes
including cell fate determination, differentiation, prolifera-
tion, and apoptotic events. Processes for which Notch
signaling is crucial in mammals include left–right asymme-
try, somitogenesis, cell fate determination of the exocrine
and endocrine pancreas, neural stem cell proliferation and
differentiation, and development of the sensory hair cells of
the inner ear (Apelqvist et al., 1999; De Bellard et al., 2002;
Hrabe de Angelis et al., 1997; Kiernan et al., 2001; Kim and
Hebrok, 2001; Przemeck et al., 2003). It is not known,
however, whether Notch signaling is involved in pituitary
gland development. Studies in other organs have suggested
that Notch acts downstream of Shh, Fgf, and TGFh family
members, influencing expression of transcription factors
including Pitx2. All of these genes have proven roles in
pituitary development (Ericson et al., 1998; Suh et al., 2002;
Treier et al., 1998, 2001), and therefore, we hypothesized
that Notch signaling might be involved in pituitary organ-
ogenesis. In this study, we show for the first time that Notch
signaling components are developmentally regulated in the
embryonic pituitary, with temporal and spatial patterns that
implicate this pathway in pituitary gland organogenesis.
Importantly, we demonstrate a correlation between Notch2
expression and the differentiation of Prop1-dependent cell
lineages.
Little is known about the mechanism whereby different
parts of RP are committed to anterior lobe versus interme-
diate lobe fates. The rostral side of RP undergoes expansion
to produce the anterior lobe, while the caudal side of the
pouch expands very little. Thus, the decision to become
intermediate or anterior lobe must involve differential
growth regulation. Studies with Tpit-deficient mice reveal
that cells ordinarily committed to become intermediate lobecan adopt anterior lobe fates, suggesting that the cells in RP
are an equivalence group (Pulichino et al., 2003). While
several components of the genetic program that controls
anterior lobe development are known, specific regulators of
melanotrope commitment and differentiation remain to be
identified. We have shown that expression of the Notch
ligand Dll3 is initiated in melanotropes as they differentiate
at 14.5 dpc and is maintained in this lineage into adulthood.
Dll3, like other melanotrope markers, such as Pomc1, Tpit,
and NeuroD1, appears to be expressed in corticotropes,
albeit transiently. Dll3 expression is developmentally regu-
lated in many developing tissues including the presomitic
and somitic mesoderm, the CNS, and the epiblast. Analysis
of Dll3 null mutant embryos generated by gene targeting
(Dunwoodie et al., 2002) and the spontaneous Dll3 pudgy
mouse mutant (Kusumi et al., 1998) revealed the essential
role of this gene in somite formation and skeletogenesis.
This aspect of Dll3 function is conserved in humans, as
DLL3 mutations have been identified in humans with
vertebral malsegmentation syndrome spondylocostal dys-
plasia (SD). There is no difference in the number or location
of melanotropes or corticotropes in Dll3 null mice, indicat-
ing that Dll3 is not required for the initial differentiation of
these lineages. However, Dll1 is expressed in the melano-
tropes at 14.5 dpc and also in the pre-corticotropes at 12.5
dpc, raising the possibility that Dll3 and Dll1 may be
functionally redundant in melanotrope and corticotrope
differentiation. Functional redundancy also appears to occur
in the developing spinal cord, where Dll3 and Dll1 are
expressed in partially overlapping subsets of postmitotic
neural progenitors (Dunwoodie et al., 1997; Kusumi et al.,
2001). This idea is supported by the absence of a neural
phenotype in patients with SD (Bulman et al., 2000). While
it would be useful to test the role of Dll1 in pituitary
development directly by loss-of-function studies, this would
require a conditional mutagenesis approach, as Dll1 null
embryos die between 10.5 and 11.5 dpc (Hrabe de Angelis
et al., 1997), too early for analysis of pituitary cell specifi-
cation. The expression patterns of Dll1 and Dll3 suggest that
these genes could have roles in regulation of differential
L.T. Raetzman et al. / Developmental Biology 265 (2004) 329–340338growth and differentiation of the anterior versus intermedi-
ate lobes.
Notch2 expression is developmentally regulated in many
tissues including the neuroectoderm, vasculature, branchial
arches, and somites (Hamada et al., 1999). Targeted muta-
tions of Notch2 have shown that this gene is essential for
normal development of the nervous system, kidney, eye, and
heart (Hamada et al., 1999; McCright et al., 2001, 2002),
although the precise role of Notch2 within these tissues is
not clear. We have shown that Notch2 is expressed at 12.5
and 14.5 dpc in the cells that lie adjacent to the residual
lumen of RP. Notch2 is not expressed in the differentiated
cells that occupy the ventro-anterior quadrant of the gland.
Down-regulation of Notch2 expression in differentiated
corticotropes and rostral tip thyrotropes suggests that ab-
sence of Notch signaling may be important to permit
differentiation. Several lines of evidence support the idea
that Notch2 and Prop1 interact. Notch2 and Prop1 expres-
sion patterns overlap, Notch2 expression is dependent on
Prop1, and Notch2 gene contains several putative PROP1
consensus-binding sites. Prop1 alone, however, is insuffi-
cient for ectopic activation of Notch2, because Notch2
expression is normal in transgenic embryos that express
Prop1. The fact that Notch2 expression is normal in mice
deficient in Hesx1 (a gene expressed just before Prop1 and
dependent upon Prop1 for repression) suggests that Notch2
deficiency is specific to Prop1 (data not shown).
In contrast to Notch2, Dll1 expression is elevated in
Prop1-deficient mice. These data raise the possibility that
Dll1 is normally repressed by Prop1. However, this is
unlikely as Dll1 and Prop1 are co-expressed in pituitary
progenitor cells. A more likely possibility is that a lateral
inhibition mechanism similar to that reported in other sys-
tems (de la Pompa et al., 1997; Heitzler et al., 1996) also
operates in the embryonic pituitary. A critical feature of
lateral inhibition is that progenitor cells within an equiva-
lence group are sensitive to the level of ligand expressed by
neighboring cells, that is, Notch ligand expression is down-
regulated in cells that neighbor the Delta positive cell
through activation of their Notch signaling pathway. In
Prop1 mutants, which have little or no NOTCH2 in the
pituitary, Notch ligand expression is not down-regulated,
resulting in an excess of Dll1 positive cells. This possibility
is supported be the ability of DLL1 to bind NOTCH2 and
activate Notch signaling, as has been shown by others
(Shimizu et al., 2000). While the precise mechanism remains
to be determined, these data provide the first evidence of
lateral inhibition in the developing pituitary, and could be
further be explored using gain-of-function and loss-of-func-
tion mutations in Notch2 signaling pathway genes.
Alteration of Notch2 and Dll1 expression in the Prop1
mutant pituitary indicates that perturbation of Notch2 sig-
naling occurs in this mutant. To investigate the possible
consequences of this signaling defect in more detail, we
examined the expression of the Hairy and Enhancer of Split
homologs Hes1 and Hes6. We have shown that these genesare spatially and temporally restricted in the pituitary,
consistent with a developmental role. However, expression
of Hes1 and Hes6 was unaltered in Prop1 mutants, indicat-
ing that these targets of Notch signaling are not downstream
of NOTCH2 in the pituitary. These data are consistent with
the studies of Hamada et al. (1999), who showed that Hes1
expression is not altered in the CNS of 9.5 dpc Notch2
mutant embryos. Therefore, Hes1 expression does not
appear to require NOTCH2, at least within the CNS and
pituitary. Our data also suggest that Hes1 expression in the
pituitary may be responsive to a different Notch receptor,
such as Notch3, with which it is co-expressed. Hes1 is
known to repress neuronal differentiation (Bae et al., 2000),
and its expression only in the undifferentiated cells of RP
would be consistent with a role in maintaining these cells as
precursors. In contrast, Hes6 is thought to promote neural
differentiation (Bae et al., 2000, Koyano-Nakagawa et al.,
2000) and repress myogenic differentiation (Cossins et al.,
2002; Gao et al., 2001). The presence of Hes6 in the early
development of the anterior lobe could be necessary either
to promote development of these cells or to prevent prema-
ture hormone expression. Expression analysis of specific
targets of NOTCH2-mediated signaling should provide
further insight into the consequences of Prop1 mutation.
The mechanism by which Prop1 controls anterior pi-
tuitary development is of particular interest as this gene is
essential for differentiation of four of the five differenti-
ated cell types and is the most common genetic cause of
combined pituitary hormone deficiency (CPHD) in
humans. The Prop1df/df pituitary is morphologically nor-
mal at 12.5 dpc, but by 14.5 dpc has an abnormal
branched morphology due to an overabundance of the
peri-luminal cells and a deficiency of cells in ventro-
anterior domain (Raetzman et al., 2002). This defect does
not result from obvious alterations in cellular proliferation
or cell death rates (Raetzman et al., 2002). The apparent
excess of peri-luminal progenitor cells in the Prop1 mutant
indicates that this gene may be required for progression of
progenitor cells to a differentiated phenotype. As Notch2
is not expressed in the Prop1df/df pituitary at 14.5 dpc,
signaling events mediated by Notch2 may therefore be
necessary for progenitor cell differentiation. In this respect,
the role of Notch2 in the pituitary may differ from other
tissues such as the cerebellum and blood, where Notch2
functions as an inhibitor of cell differentiation (Ingles-
Esteve et al., 2001; Solecki et al., 2001). Alternatively, the
absence of NOTCH2 in the Prop1 mutants may cause
pituitary cells to differentiate prematurely, but not become
fully specified. This process may involve other members
of the Notch signaling family, such as Notch3 and Dll1
that are expressed in the progenitor cells at 14.5 dpc and
down-regulated during differentiation. These studies also
indicate that the role of Prop1 may be similar to that of
Mash1 in controlling the timing of cell differentiation by
modulating the Notch signaling pathway (Casarosa et al.,
1999).
L.T. Raetzman et al. / Developmental Biology 265 (2004) 329–340 339Our studies have revealed that Notch signaling genes are
expressed in the developing pituitary and therefore are likely
to play a role in differentiation of hormone-producing cells.
In addition, we have revealed an interaction between Prop1
and Notch2, implicating a role of Notch2 in the differenti-
ation of Prop1-dependent lineages. Preliminary examination
of a Notch2 hypomorph (McCright et al., 2001) indicates
that pituitary morphology and cell specification is normal
just before birth (data not shown). However, as Notch2 null
mice die too early to examine pituitary cell specification, a
conditional mutagenesis approach will be necessary to
explore directly the functional role of Notch2 in pituitary
development. Future studies examining a pituitary-specific
deletion of Notch2 will be necessary to confirm its impor-
tance in the development of the pituitary gland.Acknowledgments
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